- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03500718
Changes in the Threshold of Electrically Evoked Compound Action Potential in Children Following Cochlear Implantation
February 20, 2020 updated by: Dr. Aparna Das, Jawaharlal Institute of Postgraduate Medical Education & Research
After cochlear implantation, cochlear nerve is stimulated by giving a current over the electrodes placed in the cochlea and the current is measured by electrically evoked Compound Action Potential (ECAP).This ECAP is measured intra operatively, after 4 weeks( at switch on), after 3months and 6 months following cochlear implantation.
Study Overview
Detailed Description
After cochlear implantation, cochlear nerve is stimulated by giving a current over the electrodes placed in the cochlea and the current is measured by electrically evoked Compound Action Potential (ECAP).This ECAP is measured intra operatively, 4 weeks(at switch on) and after 3months and 6 months following cochlear implantation.
Neural Response Telemetry (NRT) is a quick and non-invasive way of recording ECAP of the peripheral auditory nerves in-situ.
It gives clinicians valuable information for programming the T- (Threshold) and C-(Comfort) - levels of the recipient's speech processor map.
Intraoperative NRT in conjunction with electrode impedance data can help indicate the integrity of the implanted electrodes and the electrode/auditory nerve interface, confirming that the implant is functioning correctly intraoperatively.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Puducherry, India, 605006
- JIPMER
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 6 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All children between 1 and 6 years of age undergoing cochlear implantation in JIPMER during the study period.
Exclusion Criteria:
- Incomplete electrode array insertion.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Pediatric patients with bilateral sensorineural hearing loss
One group will be studied: Patients undergoing cochlear implantation surgery between age 1 and 6 years who meet the above inclusion and exclusion criteria seen in JIPMER during the study period.
|
After cochlear implantation, cochlear nerve is stimulated by giving a current over the electrodes placed in the cochlea and the current is measured by electrically evoked Compound Action Potential (ECAP).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in threshold of ECAP after cochlear implantation.
Time Frame: during implantation, at switch on( 4 weeks), after 3months and 6months.
|
To evaluate changes in threshold of ECAP during cochlear implantation, at switch on( 4 weeks), after 3 months and 6 months following cochlear implantation.
|
during implantation, at switch on( 4 weeks), after 3months and 6months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlate the amplitude of ECAP with T & C levels.
Time Frame: 2 years
|
Correlating the amplitude of ECAP with threshold and comfortable levels and creating a MAP.
|
2 years
|
Correlate amplitude of ECAP with cochlear nerve diameter measured pre-operatively.
Time Frame: 2 mins
|
By correlating amplitude of ECAP with cochlear nerve diameter we can determine the site to be operated preoperatively.
|
2 mins
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kim JR, Abbas PJ, Brown CJ, Etler CP, O'Brien S, Kim LS. The relationship between electrically evoked compound action potential and speech perception: a study in cochlear implant users with short electrode array. Otol Neurotol. 2010 Sep;31(7):1041-8. doi: 10.1097/MAO.0b013e3181ec1d92.
- van Eijl RH, Buitenhuis PJ, Stegeman I, Klis SF, Grolman W. Systematic review of compound action potentials as predictors for cochlear implant performance. Laryngoscope. 2017 Feb;127(2):476-487. doi: 10.1002/lary.26154. Epub 2016 Nov 2.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 26, 2018
Primary Completion (ACTUAL)
December 31, 2019
Study Completion (ACTUAL)
December 31, 2019
Study Registration Dates
First Submitted
April 2, 2018
First Submitted That Met QC Criteria
April 15, 2018
First Posted (ACTUAL)
April 18, 2018
Study Record Updates
Last Update Posted (ACTUAL)
February 24, 2020
Last Update Submitted That Met QC Criteria
February 20, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- JIP/IEC/2017/0339
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Confidentiality regarding patient's participation in the study will be maintained throughout the study period as well as after completion of the study.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cochlear Hearing Loss
-
Oticon MedicalTerminatedHearing Loss, Sensorineural | Hearing Loss, Bilateral | Cochlear Hearing Loss | Hearing Loss, CochlearFrance
-
Hospices Civils de LyonCompletedHearing Loss | Deafness | Cochlear Hearing Loss | Cochlear Nerve Deafness | Cochlear DiseasesFrance
-
Cambridge University Hospitals NHS Foundation TrustAdvanced Bionics AGCompletedHearing Loss, Bilateral | Cochlear Implant | Hearing Loss, Cochlear | Severe-Profound Hearing LossUnited Kingdom
-
CochlearTerminatedTinnitus, Hearing Loss, Cochlear Implant UsersNetherlands
-
University GhentUniversity Hospital, GhentRecruitingHearing Loss, Sensorineural | Cochlear Hearing Loss | Cochlear SynaptopathyBelgium
-
NYU Langone HealthWithdrawnCochlear Hearing Loss | Cochlear ImplantUnited States
-
Oticon MedicalWithdrawnCochlear Hearing Loss | Cochlear Trauma
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedSensorineural Hearing Loss | Cochlear Hearing LossFrance
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium
Clinical Trials on Cochlear implant
-
University of North Carolina, Chapel HillMed-El CorporationCompletedMeniere's Disease | Unilateral Acoustic NeuromaUnited States
-
Nantes University HospitalRecruitingProfound Bilateral Hearing LossFrance
-
CochlearCompletedSingle Sided DeafnessUnited States
-
Western University, CanadaLawson Health Research Institute; Academic Medical Organization of Southwestern... and other collaboratorsRecruiting
-
CochlearCompleted
-
MED-EL Elektromedizinische Geräte GesmbHRecruitingSensorineural Hearing Loss, BilateralFrance
-
Med-El CorporationTerminatedHearing LossUnited States, Canada
-
University of NottinghamNottingham University Hospitals NHS TrustNot yet recruiting
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium